HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lucia Russo Selected Research

CEACAM1 Protein

1/2021Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.
11/2020Loss of Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Links Nonalcoholic Steatohepatitis to Atherosclerosis.
1/2019Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.
1/2018Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis.
1/2018Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene.
12/2017Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.
12/2016Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.
5/2016Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.
4/2016PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
8/2015Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lucia Russo Research Topics

Disease

14Insulin Resistance
11/2020 - 08/2013
8Hyperinsulinism (Hyperinsulinemia)
11/2020 - 08/2013
7Abdominal Obesity
11/2020 - 08/2013
6Obesity
01/2020 - 01/2014
5Fibrosis (Cirrhosis)
01/2021 - 04/2011
5Inflammation (Inflammations)
01/2021 - 03/2012
5Fatty Liver
01/2019 - 08/2013
2Liver Diseases (Liver Disease)
01/2021 - 01/2013
2Non-alcoholic Fatty Liver Disease
01/2021 - 11/2020
2Dyslipidemias (Dyslipidemia)
11/2020 - 11/2016
2COVID-19
10/2020 - 10/2020
2Hyperphagia (Overeating)
01/2019 - 12/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 04/2016
2Body Weight (Weight, Body)
01/2018 - 10/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2013 - 12/2012
2Portal Hypertension
01/2013 - 05/2012
2Thyroid Neoplasms (Thyroid Cancer)
12/2011 - 09/2007
1Infections
01/2022
1Hyperthyroidism
07/2021
1Diabetes Mellitus
04/2021
1Umbilical Hernia (Omphalocele)
04/2021
1Macroglossia
04/2021
1Hypercholesterolemia
11/2020
1Atherosclerosis
11/2020
1Hyperglycemia
10/2020
1Atrioventricular Block
01/2019
1Cardiotoxicity
01/2019
1Supraventricular Tachycardia
01/2019
1Thrombosis (Thrombus)
11/2018
1Cardiovascular Abnormalities
01/2018
1Type 2 Diabetes Mellitus (MODY)
11/2016
1Glucose Intolerance
04/2014
1Alcoholic Fatty Liver
01/2014
1Autoimmune Diseases (Autoimmune Disease)
04/2013
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2013
1Seizures (Absence Seizure)
12/2012
1Reperfusion Injury
03/2012
1Anaplastic Thyroid Carcinoma
12/2011
1Adenoma (Adenomas)
12/2011
1Neoplasms (Cancer)
12/2011
1Carcinoma (Carcinomatosis)
12/2011
1Papillary Carcinoma
09/2007

Drug/Important Bio-Agent (IBA)

14CEACAM1 ProteinIBA
01/2021 - 08/2013
13Insulin (Novolin)FDA Link
01/2021 - 08/2013
7LipidsIBA
01/2018 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
04/2021 - 04/2016
3Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2019 - 12/2016
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 05/2012
2Pharmaceutical PreparationsIBA
01/2019 - 11/2016
2LeptinIBA
01/2019 - 05/2016
2Fenofibrate (CiL)FDA LinkGeneric
11/2016 - 05/2012
2Fatty Acids (Saturated Fatty Acids)IBA
11/2016 - 08/2013
2Messenger RNA (mRNA)IBA
04/2016 - 09/2007
2AutoantibodiesIBA
04/2013 - 12/2012
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2021
1Niacin (Nicotinic Acid)FDA LinkGeneric
01/2021
1AdipokinesIBA
01/2021
1Insulin ReceptorIBA
11/2020
1Nitric Oxide Synthase (NO Synthase)IBA
11/2020
1Endothelin-1 (Endothelin 1)IBA
11/2020
1AlbuminsIBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1GlucocorticoidsIBA
10/2020
1cholesterol 25-hydroxylaseIBA
01/2020
1Aripiprazole (Abilify)FDA Link
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
01/2019
1edoxabanIBA
11/2018
1AnticoagulantsIBA
11/2018
1Retinoid X Receptor alphaIBA
01/2018
1Exenatide (Byetta)FDA Link
01/2018
1Rosiglitazone (Avandia)FDA Link
10/2016
1pirinixic acidIBA
04/2016
1Triglycerides (Triacylglycerol)IBA
08/2015
1Estrogens (Estrogen)FDA Link
04/2014
1Prorenin ReceptorIBA
08/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1ProteomeIBA
04/2013
1AutoantigensIBA
04/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2012
1Transcription Factors (Transcription Factor)IBA
05/2012
1LigandsIBA
05/2012
1Simvastatin (Zocor)FDA LinkGeneric
03/2012
1SolutionsIBA
03/2012
1Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
03/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012
1Vasodilator Agents (Vasodilators)IBA
03/2012
1RacivirIBA
12/2011
1Carbon Tetrachloride (Tetrachloromethane)IBA
04/2011
1ThrombomodulinIBA
04/2011
1Cyclin-Dependent Kinase Inhibitor p27IBA
09/2007
1MicroRNAs (MicroRNA)IBA
09/2007

Therapy/Procedure

3Therapeutics
04/2021 - 11/2018
2Intraperitoneal Injections
01/2019 - 01/2018
1Critical Care (Surgical Intensive Care)
01/2022
1Transplantation
03/2012